Samples of the Wyss Institute's Human Organs-on-Chips were formally acquired by The Museum of Modern Art (MoMA) of New York City on March 2, 2015, and are on display in MoMA's latest Architecture and Design Exhibition, "This Is For Everyone: Design For The Common Good", until January 2016. The human organs-on-chips were recognized by Paola Antonelli, the museum's senior curator in the Department of Architecture and Design, for their state-of-the-art design and rendering which allows them to e...| Wyss Institute
By Lindsay Brownell (BOSTON) — Today, a new exhibit called AI: More than Human opens at the Barbican Centre in London, and aims to tell the rapidly developing story of artificial intelligence via a survey of today’s cutting-edge creative and scientific developments that are questioning what it means to be human. Among the projects featured...| Wyss Institute
By Lindsay Brownell (BOSTON) — Nature has a knack for producing things that seem to be perfectly designed for their place in the world: the sticky pads on geckos’ feet that help them grip slick surfaces, the way sunflowers turn to ‘follow” the sun throughout the day, the shape of snakes’ scales that allow them...| Wyss Institute
Viewpoint from our Founding Donor| Wyss InstituteWyss Institute
Collaboration catalyzes industry progress| Wyss InstituteWyss Institute
The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. You wouldn’t eat a new snack without a nutrition label on the package listing the ingredients, right? Haritosh Patel wants the same to be true for the air you breathe inside buildings.| Wyss InstituteWyss Institute
Chen has been recognized “for pioneering contributions and leadership in cell and tissue engineering, particularly in the micro-nano-bio engineering of cell and tissue assembly, structure, mechanics, and function"| Wyss InstituteWyss Institute
An annual honor celebrating the unheralded heroes of science and medicine| Wyss InstituteWyss Institute
Human lung alveolus chip infection model enables investigation of viral replication, inflammatory responses, and genetic off-target effects of a novel pan-influenza CRISPR therapy| Wyss InstituteWyss Institute
By Jessica Leff Imagine you’re a researcher who has answered pressing scientific questions and overcome challenges to develop an innovative way to detect pathogens. In addition to technical feasibility, there are other essential factors to consider when translating your work effectively from a benchtop diagnostic to a bedside point-of-care test. What application should you prioritize?...| Wyss Institute
Breakthrough aims to shorten the time women wait for effective treatment from an average of five years to just five months| Wyss InstituteWyss Institute
The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. Namita Sarraf loves to find herself at intersections, whether it’s pursuing a Ph.D. at the nexus of bioengineering and computer science or hosting a...| Wyss Institute
Over 15 million Americans are at risk of anaphylaxis, a severe allergic reaction triggered by exposure to certain foods, materials, medications, and insect bites. Every three minutes, a food reaction sends someone to the emergency room. In most individuals, anaphylactic shock can be prevented by administering the counteracting drug epinephrine, as soon as an attack...| Wyss Institute
StataDX licensed the eRapid portable electrochemical sensing technology to develop diagnostics for neurological, cardiovascular, and renal diseases with a first focus on building a point-of-care platform for difficult-to-detect neurological disorders.| Wyss Institute
Humans of the Wyss Simon D’Oelsnitz on PFASense| Wyss Institute
The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. Simon D’Oelsnitz always keeps the potential applications of his science at the top of mind. When he studied pharmacology, he thought about the customers...| Wyss Institute
Elliot is Chairman of the Roberta and Stephen R. Weiner Department of Surgery and Surgeon-in-Chief at Beth Israel Deaconess Medical Center (BIDMC). Dr. Chaikof has promoted alliances of clinicians, engineers, chemists, and biologists and in the process developed biologically-inspired materials, devices, and pharmacotherapeutics based upon the principles of molecular engineering and nanofabrication technologies. These endeavors...| Wyss Institute
Every year the Wyss Institute names a class of Validation Projects whose teams receive dedicated funding, business development support, and other resources to advance their promising technologies towards commercialization. They also collaborate with key opinion leaders, investors, and potential customers to de-risk their innovations and speed their progress to the market. This year, we’re thrilled...| Wyss Institute
At the Wyss Institute, we have a long history of celebrating the intersection of science and art, drawing inspiration from what we see in the lab and outside in Nature. The art world has recognized this connection too, with Wyss work featured in exhibits at Cooper Hewitt, MoMA, and the Barbican Centre. To continue honoring...| Wyss Institute
Throughout recent years, the Wyss’ Validation Project mechanism has proven to be a highly valuable instrument for selecting and kick-starting projects with early potential for positive impact on healthcare and the environment. Reaching deep into areas with major unmet needs across the diverse Grand Challenges laid out by the Institute, the newly selected projects are...| Wyss Institute
The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. Anastasia Ershova loves fencing because every opponent is a new puzzle to solve, and both fencers are constantly engaged, making adjustments based on each...| Wyss Institute
Handheld electrochemical sensors have revolutionized at-home medical testing for diabetics, but they have not yet been successfully applied to diagnosing other conditions. These sensors are based on the activity of an enzyme, and there are only a limited number of enzymes that can be used to detect biomarkers of human disease. An alternative, much more...| Wyss Institute
By Alexandra Jirstrand (BOSTON) – The Wyss Institute for Biologically Inspired Engineering at Harvard University has been awarded funding from Wellcome Leap’s $50 million The Missed Vital Sign program, which seeks to transform how menstruation is understood and treated in healthcare. The Wyss will use its pioneering Organ Chip technology to create the first human...| Wyss Institute
By Alexandra Jirstrand (BOSTON) – The Wyss Institute at Harvard University, its Board of Directors, and Executive Leadership are pleased to announce that Natalie Artzi, Ph.D., has been appointed to a newly created position as Associate Institute Director of the Wyss Institute. In her new role, Artzi will work closely with the Wyss Founding Director...| Wyss Institute
The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. Sayo Eweje loves finding solutions, whether he’s looking at a Rubik’s Cube or a technical challenge in the lab. When faced with the problem...| Wyss Institute
By Lindsay Brownell (BOSTON) — Getting medicines into the cells they’re designed to treat is a perennial problem for the medicine and pharmaceutical industries, and patients often suffer from side effects and ineffective treatments as a result. Current drug delivery vehicles carry a host of risks and limits: lipid nanoparticles can cause immune reactions and...| Wyss Institute
By Don Ingber Credit: Wyss Institute at Harvard University On April 11, we at the Wyss Institute welcomed more than 550 researchers, industry leaders, physicians, and entrepreneurs to our Annual Retreat in which we shared the amazing progress our community has made in the development of new bioinspired diagnostics, devices, and therapeutics for both human...| Wyss Institute
Donald E. Ingber, M.D., Ph.D., is the Founding Director of the Wyss Institute for Biologically Inspired Engineering at Harvard University, Judah Folkman Professor of Vascular Biology at Harvard Medical School and the Vascular Biology Program at Boston Children’s Hospital, and Hansjörg Wyss Professor of Biologically Inspired Engineering at the Harvard John A. Paulson School of...| Wyss Institute
By Benjamin Boettner This video explains the basic principles of eRapid as an electrochemical sensing platform, and how it could be used for low-cost, multiplexed detection of a wide range of biomolecules for diagnostic applications. Credit: Wyss Institute at Harvard University (BOSTON) – In an article published in the prestigious Accounts in Chemical Research, Wyss...| Wyss Institute
Michael Levin, a Distinguished Professor in the Biology department at Tufts, holds the Vannevar Bush endowed Chair and serves as director of the Allen Discovery Center at Tufts and the Tufts Center for Regenerative and Developmental Biology. Recent honors include the Scientist of Vision award and the Distinguished Scholar Award. His group’s focus is on understanding...| Wyss Institute
Study suggests a pain relief drug that can quickly and reversibly induce a sleep-like state in cells and organs could facilitate organ transplantation and prevent irreversible tissue injury| Wyss Institute
Wyss Institute’s Biostasis team advances science right on schedule| Wyss Institute